ELOXX PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $22.8M | $45.1M | $42.3M |
| FY2022 | $31.8M | $21.1M | $19.2M |
| FY2023 | $24.3M | $1.7M | $1.1M |
| FY2024 | $27.3M | $3.0M | $111.0K |
| FY2025 | $17.2M | $5.3M | $4.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $22.8M | $45.1M | $42.3M |
| FY2022 | $31.8M | $21.1M | $19.2M |
| FY2023 | $24.3M | $1.7M | $1.1M |
| FY2024 | $27.3M | $3.0M | $111.0K |
| FY2025 | $17.2M | $5.3M | $4.8M |